An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Ikari Y, Kurita T, Kaitani K, Sugimoto A, Ogata N, Ikuta A, Hashimoto K, Ishibashi Y, Masuda K, Miyabe T, Ono K, Kimura T.
Yamamoto K, et al. Among authors: sugimoto a.
Eur Heart J Cardiovasc Pharmacother. 2024 Oct 23:pvae075. doi: 10.1093/ehjcvp/pvae075. Online ahead of print.
Eur Heart J Cardiovasc Pharmacother. 2024.
PMID: 39444052